Connect Biopharma Holdings Limited
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTB and other ETFs, options, and stocks.About CNTB
Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease.
CNTB Key Statistics
Stock Snapshot
With a market cap of 155.55M, Connect Biopharma Holdings Limited(CNTB) trades at $2.47. The stock has a price-to-earnings ratio of -2.03.
During the trading session on 2026-08-19, Connect Biopharma Holdings Limited(CNTB) shares reached a daily high of $2.58 and a low of $2.45. At a current price of $2.47, the stock is +1.0% higher than the low and still -4.2% under the high.
Trading volume for Connect Biopharma Holdings Limited(CNTB) stock has reached 290.39K, versus its average volume of 454.23K.
Over the past 52 weeks, Connect Biopharma Holdings Limited(CNTB) stock has traded between a high of $3.82 and a low of $1.23.
Over the past 52 weeks, Connect Biopharma Holdings Limited(CNTB) stock has traded between a high of $3.82 and a low of $1.23.
CNTB News
Reports Q2 revenue $2.77M, consensus $4.42M. “During the second quarter, we achieved important milestones with the completion of enrollment in both our Phase 2...
In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on Connect Biopharma Holdings, with a price target of $10.00. Claim 55% Off Ti...
...
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.